{"id":"https://openalex.org/W2002176182","doi":"https://doi.org/10.2174/0929867033457557","title":"Iron Chelators as Anti-Neoplastic Agents: Current Developments and Promise of the PIH Class of Chelators","display_name":"Iron Chelators as Anti-Neoplastic Agents: Current Developments and Promise of the PIH Class of Chelators","alternate_titles":[],"publication_year":2003,"publication_date":"2003-06-01","ids":{"openalex":"https://openalex.org/W2002176182","doi":"https://doi.org/10.2174/0929867033457557","mag":"2002176182","pmid":"https://pubmed.ncbi.nlm.nih.gov/12678675"},"language":"en","primary_location":{"id":"doi:10.2174/0929867033457557","doi":"https://doi.org/10.2174/0929867033457557","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0929867033457557","pdf_url":null,"source":{"id":"https://openalex.org/S33159018","display_name":"Current Medicinal Chemistry","issn_l":"0929-8673","issn":["0929-8673","1875-533X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2002176182"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055735150","display_name":"David B. Lovejoy","orcid":"https://orcid.org/0000-0002-5331-8659","observed_orcids":["https://orcid.org/0000-0002-5331-8659"]},"institutions":[{"id":"https://openalex.org/I4210112315","display_name":"Children's Cancer Institute Australia","ror":"https://ror.org/01x784220","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210112315"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. Lovejoy","raw_affiliation_strings":["Children's Cancer Institute Australia for Medical Research, The Iron Metabolism and Chelation Program, PO Box 81, High St, Randwick, Sydney, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Institute Australia for Medical Research, The Iron Metabolism and Chelation Program, PO Box 81, High St, Randwick, Sydney, New South Wales, Australia","institution_ids":["https://openalex.org/I4210112315"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061763563","display_name":"Des Raymond Richardson","orcid":"https://orcid.org/0000-0002-5506-3274","observed_orcids":["https://orcid.org/0000-0002-5506-3274","https://orcid.org/0000-0003-0960-6415"]},"institutions":[{"id":"https://openalex.org/I4210112315","display_name":"Children's Cancer Institute Australia","ror":"https://ror.org/01x784220","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210112315"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. Richardson","raw_affiliation_strings":["Children's Cancer Research Institute Australia for Medical Research, Iron Metabolism and ChelationProgram, P.O. Box 81, High St, Randwick, Sydney, New South Wales, Australia 2031,Australia","Children's Cancer Institute Australia (CCIA)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Research Institute Australia for Medical Research, Iron Metabolism and ChelationProgram, P.O. Box 81, High St, Randwick, Sydney, New South Wales, Australia 2031,Australia","institution_ids":["https://openalex.org/I4210112315"]},{"raw_affiliation_string":"Children's Cancer Institute Australia (CCIA)","institution_ids":["https://openalex.org/I4210112315"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210112315"],"apc_list":null,"apc_paid":null,"fwci":4.0941,"has_fulltext":false,"cited_by_count":105,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.93901226,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"10","issue":"12","first_page":"1035","last_page":"1049"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.49320000410079956,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.49320000410079956,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":0.2087000012397766,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.10459999740123749,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/iron-chelators","display_name":"iron chelators","score":0.996999979019165},{"id":"https://openalex.org/keywords/pyridoxal-isonicotinoyl-hydrazone","display_name":"pyridoxal isonicotinoyl hydrazone","score":0.9169999957084656},{"id":"https://openalex.org/keywords/deferoxamine","display_name":"deferoxamine","score":0.9089999794960022},{"id":"https://openalex.org/keywords/iron-starvation","display_name":"iron starvation","score":0.7929999828338623},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.8370000123977661},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.7549999952316284},{"id":"https://openalex.org/keywords/leukemia","display_name":"leukemia","score":0.8379999995231628},{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":1.0},{"id":"https://openalex.org/keywords/thiosemicarbazones","display_name":"thiosemicarbazones","score":0.9120000004768372},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.9710000157356262},{"id":"https://openalex.org/keywords/iron-overload","display_name":"iron overload","score":0.47999998927116394}],"concepts":[{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.6285171508789062},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6020773649215698},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6003654599189758},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.585618257522583},{"id":"https://openalex.org/C197404232","wikidata":"https://www.wikidata.org/wiki/Q319827","display_name":"Chelation","level":2,"score":0.5732935070991516},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.5319984555244446},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.4979417324066162},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4839777946472168},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4494086802005768},{"id":"https://openalex.org/C2780108502","wikidata":"https://www.wikidata.org/wiki/Q4915018","display_name":"Biological response modifiers","level":3,"score":0.43490681052207947},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2887553572654724},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24778369069099426},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.19217121601104736},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003676","descriptor_name":"Deferoxamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006835","descriptor_name":"Hydrazones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007501","descriptor_name":"Iron","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007501","descriptor_name":"Iron","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D007502","descriptor_name":"Iron Chelating Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/0929867033457557","doi":"https://doi.org/10.2174/0929867033457557","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0929867033457557","pdf_url":null,"source":{"id":"https://openalex.org/S33159018","display_name":"Current Medicinal Chemistry","issn_l":"0929-8673","issn":["0929-8673","1875-533X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:12678675","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12678675","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1992367796","https://openalex.org/W1502461041","https://openalex.org/W34816746","https://openalex.org/W2009447754","https://openalex.org/W2089027621","https://openalex.org/W2137403734","https://openalex.org/W1995087031","https://openalex.org/W116663061","https://openalex.org/W2134355296","https://openalex.org/W2891998879"],"abstract_inverted_index":{"The":[0,146],"chelator":[1],"currently":[2],"used":[3],"to":[4,50,54,113,177],"treat":[5],"iron":[6],"(Fe)":[7],"overload":[8],"disease,":[9],"desferrioxamine":[10],"(DFO),":[11],"has":[12],"shown":[13],"anti-proliferative":[14,103],"activity":[15,126,148,182],"against":[16],"leukemia":[17],"and":[18,25,58,118,144,153,160,183],"neuroblastoma":[19],"cells":[20],"in":[21,23,26,168,173],"vitro,":[22],"vivo":[24],"clinical":[27],"trials.":[28],"Collectively,":[29],"these":[30],"studies":[31,172],"suggest":[32],"that":[33,73,84,133],"Fe-deprivation":[34],"may":[35],"be":[36],"a":[37,128],"useful":[38],"anti-cancer":[39],"strategy.":[40],"However,":[41,170],"the":[42,67,92,101,106,125,150,161],"efficacy":[43],"of":[44,69,82,91,105,116,127,131,149],"DFO":[45],"is":[46],"severely":[47],"limited":[48],"due":[49],"its":[51],"poor":[52],"ability":[53],"permeate":[55],"cell":[56],"membranes":[57],"bind":[59],"intracellular":[60],"Fe":[61,71],"pools.":[62],"These":[63],"limitations":[64],"have":[65,85,164],"encouraged":[66],"development":[68],"other":[70,154],"chelators":[72,136,155],"are":[74,89,109,134,175],"far":[75],"more":[76],"effective":[77,141],"than":[78],"DFO.":[79],"One":[80],"group":[81,130],"ligands":[83,132],"been":[86,165],"extensively":[87],"investigated":[88],"those":[90],"pyridoxal":[93],"isonicotinoyl":[94],"hydrazone":[95],"(PIH)":[96],"class.":[97],"In":[98,121],"this":[99],"review":[100],"marked":[102],"effects":[104],"PIH":[107,142,151],"analogs":[108,143,152,163],"discussed":[110],"with":[111],"reference":[112],"their":[114,179],"mechanisms":[115],"action":[117],"structure-activity":[119],"relationships.":[120],"particular,":[122],"we":[123],"discuss":[124],"novel":[129],"\"hybrid\"":[135],"derived":[137],"from":[138],"our":[139],"most":[140],"thiosemicarbazones.":[145],"anti-tumor":[147,181],"such":[156],"as":[157,185],"tachpyridine,":[158],"O-trensox":[159],"desferrithiocin":[162],"well":[166],"characterized":[167],"vitro.":[169],"further":[171],"animals":[174],"critical":[176],"evaluate":[178],"selective":[180],"potential":[184],"therapeutic":[186],"agents.":[187]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2002176182","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
